Dendritic Cell-Based Immunotherapy of Renal Cell Carcinoma

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Urologia internationalis

• Publication date

  1998-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000030291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells.

  1998cited by this paper
• Activation of human dendritic cells by bacillus Calmette-Guerin.

  1998cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Licence to kill

  1998cited by this paper
• Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2.

  1998cited by this paper
• Bacillus Calmette‐Guérin mycobacteria stimulate human blood dendritic cells

  1997cited by this paper
• Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

  1997cited by this paper
• In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy.

  1997cited by this paper
• Prostaglandin E2 and Tumor Necrosis Factor α Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production

  1997cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

  1996cited by this paper
• Human renal‐cell carcinoma tissue contains dendritic cells

  1996cited by this paper
• Phase I clinical trial: T‐cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA‐A0201‐specific peptides from prostate‐specific membrane antigen

  1996cited by this paper
• Dendritic antigen‐presenting cells from the peripheral blood of renal‐cell‐carcinoma patients

  1995cited by this paper
• Licence to kill

  1994cited by this paper
• Renal cell carcinoma.

  1956cited by this paper

• The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy

  2024cites this paper
• Sequential infusion of donor‐derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation

  2014cites this paper
• Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor.

  2008cites this paper
• Delivery of whole tumor lysate into dendritic cells for cancer vaccination.

  2008cites this paper
• Potential applications of dendritic cells

  2007cites this paper
• Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide

  2005cites this paper
• Einfluss der Aktivierung dendritischer Zellen auf die Immunantwort in vitro

  2005cites this paper
• PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.

  2005cites this paper
• Loading DCs with Ag.

  2004cites this paper
• Human renal cell carcinoma inhibits dendritic cell maturation and functions

  2004cites this paper
• Generation of canine dendritic cells from peripheral blood mononuclear cells.

  2003cites this paper
• Antigen loading of dendritic cells with whole tumor cell preparations.

  2003cites this paper
• Dendritic cell-based immunotherapy.

  2003cites this paper
• A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma

  2003cites this paper
• Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?

  2003cites this paper
• Future Directions in the Treatment of Breast Cancer – Cellular Interventions Using Dendritic Cells

  2003cites this paper
• The modulation of immunity by dendritic cells

  2003cites this paper
• DNA‐based immunotherapy: potential for treatment of chronic viral hepatitis?

  2002cites this paper
• Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression.

  2002cites this paper
• Current Methods for Loading Dendritic Cells With Tumor Antigen for the Induction of Antitumor Immunity

  2002cites this paper
• Gene therapy for urologic cancer

  2002cites this paper
• Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?

  2002cites this paper
• Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

  2002cites this paper
• Dendritic cell infiltration in a patient with seminomatous germ cell tumor of the testis: is there a relationship with infertility and tumor stage?

  2002cites this paper
• Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.

  2002cites this paper
• DENDRITIC CELLS AND THEIR EMERGING CLINICAL APPLICATIONS

  2001cites this paper
• Specific Immunotherapy of Cancer in Elderly Patients

  2001cites this paper
• Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.

  2001cites this paper
• A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells.

  2001cites this paper
• Human Gene Therapy for Urological Oncology

  2001cites this paper
• Active immunization against cancer with dendritic cells: The near future

  2001cites this paper
• Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette‐Guérin treatment

  2001cites this paper
• Active Immunization of Humans with Dendritic Cells

  2000cites this paper
• Immunologic Response to Renal Cell Carcinoma

  2000cites this paper
• Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.

  2000cites this paper
• Adoptive zelluläre Immuntherapie

  2000cites this paper
• Keyhole limpet hemocyanin (KLH): a biomedical review.

  1999cites this paper